Lisa LeCointe-Cephas - 02 May 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: SVP Chief Ethics & Com Officer
Signature: /s/ Kelly E. W. Grez as attorney-in-fact for Lisa LeCointe-Cephas
Issuer symbol: MRK
Transactions as of: 02 May 2023
Net transactions value: $0
Form type: 4
Filing time: 04 May 2023, 18:37:04 UTC
Previous filing: 03 May 2023
Next filing: 05 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MRK	Common Stock						4,155	02 May 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Stock Option (Right to Buy)	Award	$0	+9,682		$0.000000	9,682	02 May 2023	Common Stock	9,682	$117.89	Direct	F1
transaction	MRK	Restricted Stock Unit	Award	$0	+1,781		$0.000000	1,781	02 May 2023	Common Stock	1,781		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.
F2	Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3	These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.